Trial Condition(s):

Erectile Dysfunction

Study evaluating the efficacy, safety, and reliability of Vardenafil

Bayer Identifier:

100536

ClinicalTrials.gov Identifier:

NCT00661297

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Study to investigate the efficacy and safety of Vardenafil

Inclusion Criteria
- Heterosexual males
 - >/= 18 years old with ED for more than six months
 - Subjects also needed a positive first-time response to a single dose of 10mg vardenafil to be eligible for randomisation
Exclusion Criteria
- Primary hypoactive sexual desire
 - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
 - Nitrate therapy
 - Other exclusion criteria apply according to the Summary of Product Characteristics

Trial Summary

Enrollment Goal
523
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design